Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

157.70
-3.7700-2.33%
Post-market: 158.010.3100+0.20%18:50 EDT
Volume:3.38M
Turnover:536.82M
Market Cap:244.59B
PE:23.61
High:161.33
Open:160.77
Low:157.54
Close:161.47
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.34
T/O Rate:0.23%
Dividend:3.16
Dividend Rate:2.01%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.86
PE(LYR):24.11

Loading ...

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Yesterday

AstraZeneca Hedges Threat to Oncology Portfolio

Dow Jones
·
Sep 30

Bernstein Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Sep 30

Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon

Deep News
·
Sep 29

Top Premarket Gainers

MT Newswires Live
·
Sep 29

J.P. Morgan Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 29

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 29

AstraZeneca Dips Toes in Emerging Class of Cancer Drugs

Dow Jones
·
Sep 29

Hutchmed Lung-Cancer Fighting Drug Submitted to FDA for Approval

MT Newswires Live
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca Broadens Oncology Portfolio Through Summit Deal

Dow Jones
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC

TIPRANKS
·
Sep 29

AstraZeneca to Invest $2 Billion in Summit Therapeutics for Cancer Drug Tie-up

Reuters
·
Sep 29

Stocks to Watch: Summit Therapeutics, Sangoma, Navitas

Dow Jones
·
Sep 29

Summit Therapeutics, AstraZeneca enter clinical collaboration agreement

TIPRANKS
·
Sep 29

AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study

TIPRANKS
·
Sep 29

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 29

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

TradingKey
·
Sep 28

AstraZeneca Advances Friday, Outperforms Market

Dow Jones
·
Sep 26